126 related articles for article (PubMed ID: 10590264)
21. Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatibility complex (MHC) haplotype-related.
Storch MK; Bauer J; Linington C; Olsson T; Weissert R; Lassmann H
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1137-42. PubMed ID: 17146287
[TBL] [Abstract][Full Text] [Related]
22. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.
Fridkis-Hareli M; Teitelbaum D; Gurevich E; Pecht I; Brautbar C; Kwon OJ; Brenner T; Arnon R; Sela M
Proc Natl Acad Sci U S A; 1994 May; 91(11):4872-6. PubMed ID: 7515181
[TBL] [Abstract][Full Text] [Related]
23. A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11.
Pearson CI; Gautam AM; Rulifson IC; Liblau RS; McDevitt HO
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):197-202. PubMed ID: 9874795
[TBL] [Abstract][Full Text] [Related]
24. Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis.
Weissert R; Svenningsson A; Lobell A; de Graaf KL; Andersson R; Olsson T
J Immunol; 1998 Jan; 160(2):681-90. PubMed ID: 9551903
[TBL] [Abstract][Full Text] [Related]
25. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulation of experimental autoimmune encephalomyelitis with ordered peptides based on MHC-TCR binding motifs.
Ruiz PJ; DeVoss JJ; Nguyen LV; Fontoura PP; Hirschberg DL; Mitchell DJ; Garcia KC; Steinman L
J Immunol; 2001 Sep; 167(5):2688-93. PubMed ID: 11509612
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
28. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response.
Stefferl A; Brehm U; Storch M; Lambracht-Washington D; Bourquin C; Wonigeit K; Lassmann H; Linington C
J Immunol; 1999 Jul; 163(1):40-9. PubMed ID: 10384097
[TBL] [Abstract][Full Text] [Related]
29. NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations.
Tzakos AG; Fuchs P; van Nuland NA; Troganis A; Tselios T; Deraos S; Matsoukas J; Gerothanassis IP; Bonvin AM
Eur J Biochem; 2004 Aug; 271(16):3399-413. PubMed ID: 15291817
[TBL] [Abstract][Full Text] [Related]
30. Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft.
Lee C; Liang MN; Tate KM; Rabinowitz JD; Beeson C; Jones PP; McConnell HM
J Exp Med; 1998 May; 187(9):1505-16. PubMed ID: 9565642
[TBL] [Abstract][Full Text] [Related]
31. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
32. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein.
Greer JM; Sobel RA; Sette A; Southwood S; Lees MB; Kuchroo VK
J Immunol; 1996 Jan; 156(1):371-9. PubMed ID: 8598487
[TBL] [Abstract][Full Text] [Related]
33. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
[TBL] [Abstract][Full Text] [Related]
34. In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment.
Nag B; Passmore D; Deshpande SV; Clark BR
J Immunol; 1992 Jan; 148(2):369-72. PubMed ID: 1370312
[TBL] [Abstract][Full Text] [Related]
35. Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2+ T cells and encephalitogenicity in the Lewis rat.
Smeltz RB; Wauben MH; Wolf NA; Swanborg RH
J Immunol; 1999 Jan; 162(2):829-36. PubMed ID: 9916705
[TBL] [Abstract][Full Text] [Related]
36. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.
Happ MP; Wettstein P; Dietzschold B; Heber-Katz E
J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618
[TBL] [Abstract][Full Text] [Related]
37. The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI.
Reizis B; Mor F; Eisenstein M; Schild H; Stefanoviç S; Rammensee HG; Cohen IR
Int Immunol; 1996 Dec; 8(12):1825-32. PubMed ID: 8982766
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W
J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673
[TBL] [Abstract][Full Text] [Related]
39. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.
Sharma SD; Nag B; Su XM; Green D; Spack E; Clark BR; Sriram S
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11465-9. PubMed ID: 1722335
[TBL] [Abstract][Full Text] [Related]
40. Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis.
Kumar V; Urban JL; Horvath SJ; Hood L
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1337-41. PubMed ID: 1689484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
